Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic-Guided Antidepressant Prescribing (PGx-GAP) in Adolescents

NCT05965401 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT05965401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05965401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic-Guided Antidepressant Prescribing (PGx-GAP) in Adolescents
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Terminated
Start date
October 25, 2023
Completion date
May 2, 2025
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression in adolescence